Healthcare >> CEO Interviews >> November 14, 2011
Robert B. Jones has been President and Chief Executive Officer of Acura Pharmaceuticals, Inc., since July 2011 and served in that capacity on an interim basis since May 2011. He previously served as Senior Vice President and Chief Operating Officer since he joined Acura in 2008. From 2003 to 2008, Mr. Jones served first as the Vice President, Finance, and then as Vice President, Strategy and Business Analysis, of Adolor Corporation. From 2000 to 2003, he served as Vice President, Finance, and then as COO of Opt-E-Script, Inc., a privately held personalized medicine company where Mr. Jones was responsible for commercialization activities. Before that, Mr. Jones was Vice President, Sales and Marketing, for Purepac Pharmaceutical Company. He received his MBA from the University of North Carolina and a B.S. from Cornell University. Profile
TWST: Let's begin with a brief summary of Acura Pharmaceuticals and a historical sketch. Then, bring us up to date with what you see as the challenges and the opportunities for the company today.
Mr.
